Article ID Journal Published Year Pages File Type
8786180 Clinical Oncology 2018 12 Pages PDF
Abstract
WWCXB is likely to be cost-effective compared with both WWEBRT alone and radical surgery. These findings support the use of CXB boost as an adjunct to a watch and wait strategy.
Related Topics
Health Sciences Medicine and Dentistry Oncology
Authors
, , , , , , , , ,